{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-114481","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.676520+00:00","generated_at":"2026-05-30T14:41:23.180633+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Galecto appoints Dr. Amy Wechsler to Board of Directors effective October 11, 2024","bullets":["Board expanded to seven members; Wechsler appointed as Class I director with term through 2027 annual meeting.","Wechsler is board-certified in dermatology and psychiatry and serves on the Bausch Health board.","She holds an M.D. from Cornell University Medical College and an M.B.A. from Columbia Business School (2024).","Wechsler is independent under Nasdaq standards and will receive standard non-employee director compensation and equity."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-114481","json":"https://secwatch.observer/filing/0000950170-24-114481.json","markdown":"https://secwatch.observer/filing/0000950170-24-114481.md","text":"https://secwatch.observer/filing/0000950170-24-114481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/0000950170-24-114481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/glto-20241015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:41:23.180633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac1c88884c","claim":"Amy Wechsler was appointed as Director at Damora Therapeutics, Inc..","evidence_excerpt":"appointed Amy Wechsler to join the Board, effective as of October 11, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/0000950170-24-114481-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}